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Letter to Editor 
NON RESPONSIVENESS TO ECT -- AN ADDITIONAL 
PRE-REQUISITE FOR CLOZAPINE THERAPY 
Sir, 
C. Andrade in his letter published in the Indian 
Journal of Psychiatry Vol 38, No.2 Page 117, has 
suggested that non responsiveness to ECT should 
also be considered an additional pre-requisite for 
patients who are to receive clozapine. For the 
reference of the readers of Indian Journal of 
Psychiatry, I would like to mention the views of 
some of the foreign authors on this issue. The 
clinical response to ECT in schizophrenia is 
inversely proportional to duration of symptoms 
and treatment resistant patients rarely respond to 
ECT (Saizman 1980). The use of ECT combined 
with a standard neuroleptic in treatment resistant 
cases has been suggested as an alternative regi-
men (Gujavarty 1987). Meltzer (1990) has sug-
gested for a controlled clinical trial of ECT plus 
neuroleptic Vs clozapine or perhaps even ECT 
plus clozapine in treatment resistent schizophren-
ic patients. My own experience with ECT does 
not favour it's use in chronic schizophrenia 
(Pandey 1967). Andrade's suggestion should be 
taken up and controlled clinical trial with ECT 
should be initiated to resolve this question. 
S.K. PANDEY 
Care Wei Clinic 
C-20, B.D. Road, JAIPUR 
REFERENCES: 
Gujavarty K. Greenberg LB, Fink M. (1987) 
Electro Convulsive Therapy and neurolaptic med-
ication in therapy-resistant positive symptoms psy-
chosis, Convulsive Therapy; 3; 185-195. 
Meltzer Herbert Y. (1990) Clozapine and 
Electro convulsive therapy. Archives of General 
Psychiatry; 47; 290-291. 
Pandey S.K. (1967) Adreno-cortical respons-
es to ECT in cases of Schizophrenia; A thesis 
submitted for award of M.D. Rajasthan Universi-
ty-
Saizman C. (1980) The use of ECT in the 
treatment of Schizophrenia. American Journal 
of Psychiatry 137 ; 1032-1041 
Dr. Andrade replies 
Sir, 
I am grateful to Dr. Pandey for his interest in 
my views on clozapine vs ECT for treatment -
resistant schizophrenia (Andrade, 1996). I have 
the following specific responses to his com-
ments : 
a) The remarks of Saizman (1980) on the 
inverse relationship between duration of schizo-
phrenic illness and responsivity to ECT are opin-
ions based on the literature that he reviewed, and 
apply to chronic/ residual states. Salzman's views 
therefore do not contradict my stance that a trial 
of ECT should be considered before clozapine is 
prescribed for severe, positive symptom, treat-
ment - resistant schizophrenia, where the clinical 
picture is altogether different. 
Even if responsivity to ECT does prove low, 
given the favourable cost - risk - benefit ratio 
with ECT as compared with that of clozapine, an 
ECT trial remains indicated. Finally, it must be 
remembered that the goal of treatment is not a 
cure ; attenuation of symptoms by as little as 
20% may be sufficient to define treatment re-
sponse, for in treatment - resistant patients any 
improvement, however small, is a bonus (Kane, 
1988). 
b) When ECT has been used in patients who 
have responded poorly to drugs alone, in both 
controlled studies and case reports the existing 
schedule of neuroleptic medication has conven-
tionally been continued (for review, see Andrade, 
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